BGI Genomics: On February 25, net short selling was 23,000 shares, with a total net sell-off of 48,600 shares over the past 3 days.

Securities Star News: On February 25th, Huada Gene (300676) had a margin financing purchase of 23.54 million yuan, a repayment of 19.94 million yuan, with a net buy of 3.5978 million yuan. The margin financing balance was 1.079 billion yuan, with 12 out of the last 20 trading days showing net margin buying.

Regarding securities lending, on that day, 23,200 shares were sold short, 200 shares were repaid, resulting in a net short sale of 23,000 shares. The remaining securities lending balance was 176,000 shares. Over the past three trading days, there has been a continuous net short sale totaling 48,600 shares.

The total margin financing and securities lending balance was 1.087 billion yuan, up 0.45% from yesterday.

Quick Facts

Margin Financing and Securities Lending: Margin financing means a securities company lends money to investors to buy stocks. When due, the principal and interest are repaid together. Securities lending can be understood as investors borrowing stocks to sell; when due, they return the stocks and pay interest. Generally, investors buy stocks on margin if they are optimistic about the stock price, and sell short if they are bearish.